NCT03581240 2026-02-20An Intermediate Expanded Use Trial of DFMOMilton S. Hershey Medical CenterAvailable
NCT05064306 2025-08-01131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young AdultsMemorial Sloan Kettering Cancer CenterNo longer available